Elucigene DPYD

5-fluorouracil (5-FU) is a chemotherapy agent used to treat a range of cancers including colorectal, head and neck, breast, pancreatic and stomach cancer. 5-FU is metabolized by the dihydropyrimidine dehydrogenase enzyme (DPD) which is encoded by the DPYD gene.

Several variants within DPYD have been described that lead to reduced or abolished DPD activity. Patients with these variants are at an increased risk of severe or fatal 5-FU toxicity. Therefore, implementation of DPD deficiency screening by genotyping will allow a more accurate prediction of toxicity and chemotherapeutic response.

Instructions for Use Downloads

Please sign in to your Elucigene Members account or register using the links below:
Sign In
Register

Supplementary Information

Please sign in to your Elucigene Members account or register using the links below:
Sign In
Register

Catalogue Number

ONDYDB1

Kit name

KIT, Eluci, DPYD, 25T, IVD-CE

Notes

2 PCR tubes per sample, 6 mutations detected, Genetic Analyser platform